{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Xlsx":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE271nnn/GSE271179/suppl/GSE271179_NormalizedCounts_edgeR.xlsx"],"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE271nnn/GSE271179/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271179"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Transcriptome analysis of cell line/patient-derived xenograft (PDX) samples of myeloid leukemia associated with Down syndrome (ML-DS)","description":"Myeloid leukemia associated with Down syndrome (ML-DS) is a rare pediatric cancer in which 10-20% patients who are relapsed/refractory have very limited treatment options. Novel treatment options may be identified via transcriptome profiling.","dates":{"publication":"2026/06/18"},"accession":"GSE271179","cross_references":{"GSM":["GSM8371427","GSM8371426","GSM8371436","GSM8371425","GSM8371424","GSM8371435","GSM8371419","GSM8371429","GSM8371428","GSM8371430","GSM8371434","GSM8371423","GSM8371422","GSM8371433","GSM8371432","GSM8371421","GSM8371431","GSM8371420"],"GPL":["11154"],"GSE":["271179"],"taxon":["Homo sapiens"],"PMID":["[41945753]"]}}